Viewing StudyNCT00103207



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00103207
Status: COMPLETED
Last Update Posted: 2023-06-28
First Post: 2005-02-07

Brief Title: Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
cetuximab View
bronchioalveolar carcinoma BAC View
adenocarcinoma with BAC features View
stage IIIB non-small cell lung cancer View
stage IV non-small cell lung cancer View
recurrent non-small cell lung cancer View